Aptinyx Inc (APTX) Stock
APTX is no longer traded. Aptinyx was delisted from the Nasdaq in May 2023.
Prices on this page are historical; the last trade was May 18, 2023 at $0.06.
Aptinyx stock price history
APTX final trading statistics
- Final close
- $0.06
- Final trading day
- May 18, 2023
- Market cap at delisting
- $4.13M
- Shares outstanding
- 67.72M
- Final 52-week range
- $0.06 – $0.74
- Avg. volume (final 3 mo.)
- 4,425,083
- All-time high (split-adj.)
- $31.85 · Sep 2018
- All-time low (split-adj.)
- $0.06 · May 2023
- Return since IPO
- -99.7%
- Beta
- 1.22
- Book value / share
- $0.27
- Price / book
- 0.23
Aptinyx annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $0.00 | -$64.1M | -$0.96 |
| FY2021 | $1.00M | -$74.4M | -$1.11 |
| FY2020 | $1.56M | -$49.6M | -$1.05 |
| FY2019 | $3.67M | -$57.0M | -$1.71 |
| FY2018 | $6.57M | -$53.3M | -$3.13 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Aptinyx Inc
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Its lead product candidate NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase I clinical trial to treat opioid use disorder, or OUD; and in preclinical trial for the treatment of alcohol use disorder, or AUD. The company has a research collaboration agreement with Allergan plc. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois.
Aptinyx stock FAQ
What happened to Aptinyx stock?
Aptinyx stock was delisted from the Nasdaq. Its final close was $0.06 on May 18, 2023.
Is APTX stock still trading?
No. APTX was delisted from the Nasdaq in May 2023 and no longer trades on a U.S. exchange.
What was the last price of APTX stock?
APTX closed at $0.06 on its final trading day, May 18, 2023, for a market value of about $4.13M.
What were Aptinyx's revenue and earnings in its last full fiscal year?
Aptinyx reported revenue of $0.00 and net income of -$64.1M in fiscal 2022, its last full year as a public company.
When did Aptinyx go public?
Aptinyx Inc stock began trading on June 21, 2018.